Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial ...
An RNA sequencing and machine learning screening platform identified an RNA-processing factor that reduced markers of ...
First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions ...
John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through ...
The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice ...
Targeted lipid nanoparticles generate CAR NK cells in mice, showing activity against cancer and autoimmune liver disease ...
Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and why faster clinical execution will shape the next generation of medicines ...
WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas. To highlight the FDA ...
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers ...
WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas. This content is an ...
GSK's RSV vaccine Arexvy has been accepted for review by China's Center for Drug Evaluation for adults aged 60 and older. The regulatory submission is backed by positive phase 3 trial results, meeting ...
China’s rise in biopharma is often framed as a competitive challenge to the West. For Lingshi Tan, Executive Chairman of Caidya, that framing misses the larger point: drug development itself is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results